- Home
- OSRH vs ATHA Comparison
OSRH vs ATHA Comparison
Compare OSRH & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSRH
- ATHA
- Stock Information
- Founded
- OSRH N/A
- ATHA 2011
- Country
- OSRH United States
- ATHA United States
- Employees
- OSRH N/A
- ATHA N/A
- Industry
- OSRH
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- OSRH
- ATHA Health Care
- Exchange
- OSRH Nasdaq
- ATHA Nasdaq
- Market Cap
- OSRH 13.2M
- ATHA 14.8M
- IPO Year
- OSRH N/A
- ATHA 2020
- Fundamental
- Price
- OSRH $0.60
- ATHA $3.88
- Analyst Decision
- OSRH
- ATHA
- Analyst Count
- OSRH 0
- ATHA 0
- Target Price
- OSRH N/A
- ATHA N/A
- AVG Volume (30 Days)
- OSRH 988.8K
- ATHA 49.5K
- Earning Date
- OSRH 11-24-2025
- ATHA 11-06-2025
- Dividend Yield
- OSRH N/A
- ATHA N/A
- EPS Growth
- OSRH N/A
- ATHA N/A
- EPS
- OSRH N/A
- ATHA N/A
- Revenue
- OSRH $104,735.00
- ATHA N/A
- Revenue This Year
- OSRH N/A
- ATHA N/A
- Revenue Next Year
- OSRH N/A
- ATHA N/A
- P/E Ratio
- OSRH N/A
- ATHA N/A
- Revenue Growth
- OSRH N/A
- ATHA N/A
- 52 Week Low
- OSRH $0.45
- ATHA $2.20
- 52 Week High
- OSRH $13.40
- ATHA $8.26
- Technical
- Relative Strength Index (RSI)
- OSRH 45.43
- ATHA 69.37
- Support Level
- OSRH $0.53
- ATHA $3.75
- Resistance Level
- OSRH $0.76
- ATHA $4.59
- Average True Range (ATR)
- OSRH 0.05
- ATHA 0.31
- MACD
- OSRH 0.00
- ATHA -0.06
- Stochastic Oscillator
- OSRH 35.47
- ATHA 29.04
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.